51. miR-744-5p inhibits cellular proliferation and invasion via targeting ARF1 in epithelial ovarian cancer.
- Author
-
Zhao LG, Wang J, Li J, and Li QF
- Subjects
- ADP-Ribosylation Factor 1 genetics, Blotting, Western, Carcinoma, Ovarian Epithelial genetics, Cell Line, Tumor, Cell Movement genetics, Cell Movement physiology, Cell Proliferation genetics, Cell Proliferation physiology, Female, Gene Expression Regulation, Neoplastic genetics, Gene Expression Regulation, Neoplastic physiology, Humans, MicroRNAs genetics, Middle Aged, Neoplasm Invasiveness genetics, Neoplasm Invasiveness pathology, Ovarian Neoplasms genetics, ADP-Ribosylation Factor 1 metabolism, Carcinoma, Ovarian Epithelial metabolism, MicroRNAs metabolism, Ovarian Neoplasms metabolism
- Abstract
miR-744-5p has been demonstrated to play an important role in cancer progression. However, the functions of miR-744-5p in epithelial ovarian cancer (EOC) are not well clarified. In this study, our aim was to investigate the role of miR-744-5p and its underlying molecular mechanism in cell progression of EOC. EOC clinical tissues and matched adjacent ovarian epithelial tissues were collected from 18 patients. Tissues and cell lines were analyzed by qPCR or Western blot to investigate the expression of miR-744-5p and ARF1 in EOC. Cell proliferative capacity was assessed by CCK8 and colony formation assays. Wound healing and transwell assays were performed to evaluate cell migration and invasion. The potential binding relation between miR-744-5p and IRF1 was demonstrated by dual luciferase report assay. The results showed that expression of miR-744-5p was low in EOC clinical tissues and cells. Overexpression of miR-744-5p inhibited proliferation, migration, and invasion of EOC cells. Further mechanistic study identified that ARF1 is a target of miR-744-5p, which is negatively correlated with the expression of miR-744-5p, and overexpression of ARF1 could reverse the inhibition of miR-744-5p on the proliferation, migration, and invasion of EOC cells. Taken together, our results indicated that miR-744-5p attenuated EOC progression via targeting IRF1, providing potential guidance for the clinical treatment of ovarian cancer., (© 2020 The Authors. The Kaohsiung Journal of Medical Sciences published by John Wiley & Sons Australia on behalf of Kaohsiung Medical University.)
- Published
- 2020
- Full Text
- View/download PDF